Project Grant K08AI187778
Award Date
7/17/25
Completion Date
6/30/30
Dollars Obligated
$198K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award of $106,446 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) aims to establish an innovative, high-throughput method for identifying bacteriophages (phages) and their bacterial host cells within complex microbial communities like the human gut microbiome. The principal investigator will adapt a single-cell RNA sequencing (scRNA-seq) protocol to rapidly screen bacterial cells...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $453,750 to Tufts University School of Medicine to study how certain bacteriophages (viruses that infect bacteria) evade the protective mechanisms of bacteria, including some deadly pathogens like Vibrio cholerae. The project aims to determine the counter-defense mechanisms used by these phages and identify the...
This Project Grant award of $427,625.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research by Washington University to discover novel anti-biofilm agents derived from bacteriophages. The goal is to develop alternative therapies for treating biofilm-associated infections, which are a major challenge for pathogens like Pseudomonas aeruginosa. The research will isolate phages that can overcome biofilm barriers,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $380,725 to the University of California, San Diego (UCSD) to conduct research on the molecular determinants of viral receptor-binding protein evolution. The key goals are to establish a molecular model for how viral receptor-binding proteins can gain new functions, understand the constraints on their evolution, and identify...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $173,030 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to President and Fellows of Harvard College. The grant, awarded on September 25, 2024, will fund the development of a novel assay for targeted isolation of environmental bacteriophages (phages) based on their receptor dependencies. The project aims to create a generalizable technique that allows selecting phages that require...
This $377,500 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research focused on merging bacteriophage biology with microbial glycobiology. The key objectives of this 5-year project (8/1/2025 - 5/31/2030) are to: 1) Explore the mechanisms used by Campylobacter jejuni phages to replace canonical DNA bases with non-canonical bases, including investigating a new...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,388,838 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation For The State University Of New York (RF SUNY) to optimize phage cocktail regimens for treating extensively drug-resistant Pseudomonas aeruginosa. The project aims to: 1) develop a quantification assay for the phage cocktail, 2) identify optimal phage combinations and administration patterns...
This $907,800 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a universal bacterial genome editing platform based on phage recombinases. The University of Rochester is leading this research to create a broadly-functioning recombineering system that can edit the genomes of diverse bacterial species, including clinically-relevant pathogens. Key aspects...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training federal grant program (CFDA 93.859), provides $729,010.00 to Texas A&M University to conduct research on bacteriophage (phage) strategies to lyse bacterial cells. The 5-year project aims to characterize the mechanisms of novel phage lysis proteins, including those from phages infecting the human gut microbiome, using genetic, biochemical, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $229,411 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Northwestern University to investigate Neisseria gonorrhoeae double-stranded bacteriophage. The research aims to determine whether one or more phage islands can produce phage, explore the regulation of two essential LexA orthologs, and assess whether these phage(s) can infect Neisseria strains or species. This project builds upon the...